268 filings
Page 3 of 14
8-K
jxw4sihcc6v40eb4d
7 Feb 23
Larimar Therapeutics Appoints Dr. Gopi Shankar as Chief Development Officer
4:20pm
8-K
6star5ez6 ygqu5lbi
9 Jan 23
January 2023 Larimar Therapeutics Corporate Presentation
4:03pm
EFFECT
5a7 y9y01s4ah361b
22 Nov 22
Notice of effectiveness
12:15am
CORRESP
gcmytqxw1j payur3v85
18 Nov 22
Correspondence with SEC
12:00am
UPLOAD
b4asbhhg qqi
16 Nov 22
Letter from SEC
12:00am
8-K
fp3ocfly2isnj3sji18n
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
mqxky36dwk
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
8-K
cplfiasmtd3ps1
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
424B5
1m8w acw5ys7ly3n
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
w1ed06t9vynw qhgc7f1
14 Sep 22
Other Events
7:05am
8-K
6vsyj9p l4m75aa8smrj
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
z9pcrt
12 May 22
Departure of Directors or Certain Officers
4:10pm
8-K
11yitf2
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
b4t5hijoq6mnn8yx
11 Apr 22
Departure of Directors or Certain Officers
4:06pm